50 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19104909 | INFUSION SITE FAILURE DETECTION | SHELDEN, BION A | 3685 | Non-Final OA | Feb 19, 2025 |
| 18713758 | SYSTEMS AND METHODS FOR IDENTIFYING SUBJECTS FOR CLINICAL TRIALS | HEIN, DEVIN C | 3686 | Non-Final OA | May 28, 2024 |
| 18598084 | METHODS AND APPARATUSES FOR DETECTING ANOMALIES WHEN FILLING A CONTAINER WITH FLUID | KOPPOLU, VAISALI RAO | 2664 | Non-Final OA | Mar 07, 2024 |
| 18686475 | SYSTEMS AND METHODS FOR SENSING DEFECATION EVENTS | OKONAK, ELIZABETH LOUISE | 3792 | Non-Final OA | Feb 26, 2024 |
| 18567814 | 2019 NOVEL CORONAVIRUS ANTIBODY-CONTAINING PHARMACEUTICAL FORMULATIONS | WANG, RUIXUE | 1672 | Non-Final OA | Dec 07, 2023 |
| 18523645 | THERAPEUTIC USES OF DULAGLUTIDE | BEANE, RANDALL L | 1654 | Final Rejection | Nov 29, 2023 |
| 18506193 | SYNTHETIC NUCLEIC ACIDS INCLUDING ASTROCYTE-DIRECTED PROMOTER CONSTRUCTS AND METHODS OF USING THE SAME | BURKHART, MICHAEL D | 1638 | Non-Final OA | Nov 10, 2023 |
| 18288314 | SUBSTITUTED FUSED AZINES AS KRAS G12D INHIBITORS | NOLAN, JASON MICHAEL | 1623 | Non-Final OA | Oct 25, 2023 |
| 18552897 | TABLET DISPENSER | RANDALL, JR., KELVIN L | 3651 | Final Rejection | Sep 28, 2023 |
| 18549693 | USE OF MEVIDALEN AND OTHER D1 POSITIVE ALLOSTERIC MODULATORS FOR SLOWING OF PARKINSON'S DISEASE PROGRESSION | ELENISTE, PIERRE PAUL | 1622 | Non-Final OA | Sep 08, 2023 |
| 18549546 | USE OF MEVIDALEN AND OTHER D1 POSITIVE ALLOSTERIC MODULATORS IN THE TREATMENT OF HALLUCINATIONS AND DEMENTIA-RELATED PSYCHOSIS | PECKHAM, RICHARD GRANT | 1627 | Non-Final OA | Sep 07, 2023 |
| 18546477 | TIRZEPATIDE THERAPEUTIC METHODS | BROWN, DALIYAH MONYHE | 1654 | Non-Final OA | Aug 15, 2023 |
| 18262874 | METHODS AND APPARATUS FOR INCREMENTAL LEARNING USING STORED FEATURES | BROUGHTON, KATHLEEN M | 2661 | Final Rejection | Jul 25, 2023 |
| 18262010 | STATUS SENSING SYSTEMS FOR CONNECTED INJECTION DEVICE | DESANTO, MATTHEW F | 3700 | Non-Final OA | Jul 18, 2023 |
| 18260125 | ANTI-N3pGlu AMYLOID BETA ANTIBODIES AND USES THEREOF | HOPKINS, SAMANTHA LAKE | 1641 | Non-Final OA | Jun 30, 2023 |
| 18259500 | HALF-LIFE EXTENDING MOIETIES AND METHODS OF USING THE SAME | KATAKAM, SUDHAKAR | 1658 | Non-Final OA | Jun 27, 2023 |
| 18323674 | LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PROGRESSED ON A CDK4/6 INHIBITOR | NOTTINGHAM, KYLE GREGORY | 1621 | Non-Final OA | May 25, 2023 |
| 18317282 | OSCILLATING FLUIDIZED BED OLIGONUCLEOTIDE SYNTHESIZER | LAU, JONATHAN S | 1693 | Non-Final OA | May 15, 2023 |
| 18143902 | VARIANT ADENO-ASSOCIATED VIRUS (AAV) CAPSID POLYPEPTIDES AND GENE THERAPEUTICS THEREOF FOR TREATMENT OF HEARING LOSS | SHIBUYA, MARK LANCE | 1631 | Non-Final OA | May 05, 2023 |
| 18312653 | HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES | ALDARONDO, DASIA ALI | 1647 | Non-Final OA | May 05, 2023 |
| 18247084 | METHODS FOR REDUCING HOST CELL PROTEIN CONTENT IN PROTEIN PURIFICATION PROCESSES | CHHAY, BONIRATH | 1645 | Non-Final OA | Mar 29, 2023 |
| 18245425 | ORAL DRUG DELIVERY DEVICE WITH EXPANDING BAND | TRUONG, QUANGLONG N | 1615 | Non-Final OA | Mar 15, 2023 |
| 18044618 | DEVICES AND PROCESSES FOR DELIVERY OF THERAPEUTIC FLUIDS | DARB, HAMZA A. | 3783 | Non-Final OA | Mar 09, 2023 |
| 18044504 | Therapeutic Antibody Formulations | NOAKES, SUZANNE MARIE | 1656 | Non-Final OA | Mar 08, 2023 |
| 18176844 | THERAPEUTIC ANTIBODY FORMULATION | KIM, YUNSOO | 1641 | Non-Final OA | Mar 01, 2023 |
| 18041898 | METHODS AND APPARATUS FOR DISPLAYING GLUCOSE DATA | HALPRIN, MOLLY SARA | 3791 | Final Rejection | Feb 16, 2023 |
| 17787015 | ENDOTOXIN DETECTION | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Feb 06, 2023 |
| 18006593 | PHYSIOLOGICAL DATA MONITORING SYSTEM | SWEARINGEN, JEFFREY R | 2445 | Final Rejection | Jan 24, 2023 |
| 18005245 | LOW DOSE REGIMEN AND FORMULATION OF A 5-METHYL-1,2,4-OXADIAZOL-3-YL COMPOUND | MOU, LIYUAN | 1628 | Final Rejection | Jan 12, 2023 |
| 18149982 | METHODS OF USING AND COMPOSITIONS CONTAINING DULAGLUTIDE | SABILA, MERCY HELLEN | 1654 | Non-Final OA | Jan 04, 2023 |
| 18011965 | PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID BETA 1-42 | WANG, CHANG YU | 1675 | Non-Final OA | Dec 21, 2022 |
| 17920118 | PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF RESPIRATORY DISEASE | SAOUD, CHRISTINE J | 1645 | Non-Final OA | Oct 20, 2022 |
| 17906580 | FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE | BURKETT, DANIEL JOHN | 1624 | Final Rejection | Sep 16, 2022 |
| 17911746 | METHOD FOR TREATING IDH1 INHIBITOR-RESISTANT SUBJECTS | VALLE, ERNESTO | 1623 | Non-Final OA | Sep 15, 2022 |
| 17905520 | MULTISPECIFIC BINDING PROTEINS AND METHODS OF DEVELOPING THE SAME | ROONEY, NORA MAUREEN | 1641 | Non-Final OA | Sep 02, 2022 |
| 17883072 | Anti-CGRP Antibody Formulation | WANG, CHANG YU | 1675 | Final Rejection | Aug 08, 2022 |
| 17794128 | GIP/GLP1 CO-AGONIST COMPOUNDS | HELLMAN, KRISTINA M | 1654 | Non-Final OA | Jul 20, 2022 |
| 17779463 | MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | WITTLIFF, KATERINA ANNA | 3783 | Non-Final OA | May 24, 2022 |
| 17743864 | Treatment of Genital Psoriasis | JIANG, DONG | 1674 | Non-Final OA | May 13, 2022 |
| 17689286 | Methods of treating cancer using a combination of SERD Dosing Regimens | ADLAM, CHANTAL PETA-GAYE | 1622 | Non-Final OA | Mar 08, 2022 |
| 17633631 | METHODS OF MAKING INCRETIN ANALOGS | REYNOLDS, FRED H | 1658 | Final Rejection | Feb 08, 2022 |
| 17554713 | Anti-CGRP Antibody Formulation | BORGEEST, CHRISTINA M | 1675 | Non-Final OA | Dec 17, 2021 |
| 17619289 | SYSTEMS AND METHODS FOR DETECTING MISSED BOLUS DOSES | PLAYER, ROBERT AUSTIN | 1686 | Final Rejection | Dec 15, 2021 |
| 17535059 | COMPOUNDS AND METHODS TARGETING HUMAN TAU | BALLARD, KIMBERLY | 1675 | Non-Final OA | Nov 24, 2021 |
| 17439066 | INTEGRATED INSERTER/APPLICATOR FOR A DRUG DELIVERY SYSTEM PROVIDING MULTIPLE WEAR CONFIGURATIONS | THOMAN, EVELYN ANNE | 3783 | Non-Final OA | Sep 14, 2021 |
| 17462872 | ENDOCRINE THERAPY AND ABEMACICLIB COMBINATION FOR THE ADJUVANT TREATMENT OF NODE-POSITIVE, EARLY STAGE, HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER | SEITZ, ANTHONY JOSEPH | 1629 | Final Rejection | Aug 31, 2021 |
| 17433795 | MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | DARB, HAMZA A. | 3783 | Non-Final OA | Aug 25, 2021 |
| 17354195 | Antibodies that bind TGF-Alpha and Epiregulin for use in the treatment of pain | ALLEN, MARIANNE P | 1647 | Final Rejection | Jun 22, 2021 |
| 17211163 | COMBINATION THERAPY | BALLARD, KIMBERLY | 1675 | Non-Final OA | Mar 24, 2021 |
| 15733970 | COMPOSITIONS AND METHODS OF USE OF IL-10 AGENTS IN CONJUNCTION WITH CHIMERIC ANTIGEN RECEPTOR CELL THERAPY | SKELDING, ZACHARY S | 1644 | Final Rejection | Dec 01, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial